Prostatakarzinom: Apalutamid verlängert metastasenfreies Überleben
- PMID: 30731495
- DOI: 10.1055/a-0770-2761
Prostatakarzinom: Apalutamid verlängert metastasenfreies Überleben
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Comment on
-
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
